New Deal
Clint Gartin
Chairman of Investment Banking at Morgan Stanley
Financial Advisor
New York
Deal Bio
Awards
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (21)
Key Relationships
Announcement Date
Deal Value
Shire
Takeda Pharmaceutical Company
£44,351m
154 dealmakers
Consumer Health Joint Venture
Pfizer
£9,800m
78 dealmakers
Celgene Corporation
Bristol Myers Squibb Company
£70,659m
82 dealmakers
Array Biopharma
£9,049m
51 dealmakers
Allergan
Abbvie
£67,600m
99 dealmakers
OTEZLA
Amgen
£10,900m
45 dealmakers
SYNTHORX
Sanofi
£1,902m
50 dealmakers
Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)
Institutional Investors
£5,390m
17 dealmakers
GRAIL
Illumina
£6,190m
107 dealmakers
Alexion Pharmaceuticals
Astrazeneca
£29,441m
63 dealmakers
Amoun Pharmaceutical Company
Abu Dhabi Development Corporation (adq)
£538m
23 dealmakers
Ppd
Thermo Fisher Scientific
£15,220m
62 dealmakers
Aldevron
Danaher Corporation
£6,820m
52 dealmakers
Translate Bio
£2,302m
Bausch Health (eye Health Business)
value n/a
10 dealmakers
Prometheus Biosciences
Merck & Co
£8,698m
Ellab
Novo Holdings
7 dealmakers
Abcam
£4,530m
41 dealmakers
Mirati Therapeutics
£3,840m
54 dealmakers
IMMUNOGEN
£7,952m
33 dealmakers
Cerevel Therapeutics
£6,894m
53 dealmakers